Towards Healthcare
Infectious Diseases Market to Expand USD 38.19 Bn by 2034

Infectious Diseases Market 2025 Trends and Future Growth

Projections indicate that, infectious diseases industry is projected to rise from USD 21.74 billion in 2024 to USD 38.19 billion by 2034, reflecting a CAGR of 5.8% over the next decade. The continuous emergence of various pathogens, resulting in persistent diseases, rapid diagnostics, and point-of-care testing, is the major driving force behind the diversification of health conditions and associated medical treatments. North America dominated the market in 2024, led by the favorable regulatory environment and advanced healthcare infrastructure.

  • Insight Code: 6065
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The infectious diseases market holds a valuation of USD 23 billion as of 2025, and will expand to USD 38.19 billion by 2034, achieving a CAGR of 5.8% between 2024 and 2034.

North America is currently leading the infectious diseases market due to high healthcare spending, big vaccine & diagnostic markets, and strong pharma pipeline commercialization.

Some key players include Pfizer, GlaxoSmithKline, Johnson & Johnson, AstraZeneca, Gilead Sciences, etc.

Key trends include vaccine advancements, AI for surveillance, integrated DNA technologies, and pandemic preparedness frameworks.

CDC, WHO, NFID, EEID, IHR, PHAC, CFIA, HC, APCCMI